Industry: Health care Region: Denmark Transaction price: US$ 1 million Transaction method: equity investment
Project introduction:
A Danish medical equipment company, founded in 1935 and headquartered in Copenhagen, Denmark, is a pioneer in blood gas testing. Since 1954, a commercial blood gas analyzer has been developed to continuously promote the development of critical illness diagnosis solutions. The company's products and solutions are applied to hospitals, clinics and laboratories in more than 130 countries, and are committed to providing information on key parameters of emergency care diagnosis.
Product introduction:
1. Blood gas test
According to the requirements, a blood gas analyzer can be provided, and 17 critical test results such as blood gas, electrolytes, metabolites and blood oxygen can be obtained. In addition, the automatic quality management function improves the accuracy of the test results.
2. Percutaneous monitoring
Percutaneous detection is a non-invasive method, which is suitable for patients who need to continuously monitor percutaneous oxygen partial pressure and percutaneous carbon dioxide partial pressure, but can't take blood many times. Different types of percutaneous monitors can continuously monitor patients' parameters including tcpO2, tcpCO2, SpCO2 and pulse rate.
3. Immunoassay
Using bedside biomarker detection to make key decisions quickly can help speed up the diagnosis and treatment process, reduce accidents and reduce process costs.
Cooperation mode:
Seek partners who need critical illness detection solutions such as blood gas testing and percutaneous monitoring.